hydroxyurea has been researched along with Heart Septal Defects, Ventricular in 1 studies
Heart Septal Defects, Ventricular: Developmental abnormalities in any portion of the VENTRICULAR SEPTUM resulting in abnormal communications between the two lower chambers of the heart. Classification of ventricular septal defects is based on location of the communication, such as perimembranous, inlet, outlet (infundibular), central muscular, marginal muscular, or apical muscular defect.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hydroxyurea seems to be an eddicient there alternative therapy for seconday polycythemia caused by incurable cyantic congenital heart disease." | 1.34 | [Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report]. ( Békir, S; Ben Romdhane, N; Boussaada, R; Mechmèche, R, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boussaada, R | 1 |
| Békir, S | 1 |
| Ben Romdhane, N | 1 |
| Mechmèche, R | 1 |
1 other study available for hydroxyurea and Heart Septal Defects, Ventricular
| Article | Year |
|---|---|
[Chemotherapy against polycythemia due to a cyanotic congenital heart disease in adults. One case report].
Topics: Adult; Erythrocytes; Follow-Up Studies; Heart Defects, Congenital; Heart Septal Defects, Ventricular | 2007 |